Michael Haase1, Andreas Kribben, Walter Zidek, Jürgen Floege, Christian Albert, Berend Isermann, Bernt-Peter Robra, Anja Haase-Fielitz. 1. Department of Research and Science, Medical School Brandenburg Theodor Fontane (MHB); Medical Faculty, Otto-von-Guericke Universität (OvGU), Magdeburg; MVZ Diaverum, Potsdam; MHB; University Clinic for Nephrology and Hypertension, Diabetology and Endocrinology, OVGU Magdeburg; Clinic for Nephrology, Essen University Hospital; Medical Department, Division of Nephrology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin; Clinic for Renal and Hypertensive Disorders, Rheumatological and Immunological Diseases (Medical Clinic II), University Hospital Aachen; Department of Clinical Chemistry and Pathobiochemistry (IKCP), OVGU Magdeburg; Department of Social Medicine & Health Economics (ISMG), OVGU Magdeburg.
Abstract
BACKGROUND: Acute kidney injury (AKI) often takes a complicated course if diagnosed late and undertreated. Electronic alerts that provide an early warning of AKI are intended to support treating physicians in making the diagnosis of AKI and treating it appropriately. The available evidence on the effects of such alert systems is inconsistent. METHODS: We employed the PRISMA recommendations for systematic literature reviews to identify relevant articles in the PubMed, Scopus, and Web of Science databases. All of the studies that were retrieved were independently assessed by two of the authors with respect to the methods of computer-assisted electronic alert systems and their effects on process indicators and clinical endpoints. RESULTS: 16 studies with a total of 32 842 patients were identified. 8.5% of admitted patients had community-acquired or hospital-acquired AKI, with an in-hospital mortality of 22.8%. Fifteen electronic alert systems were in use throughout the participating hospitals. In 13 of 15 studies, alarm activation was accompanied by concrete treatment recommendations. A randomized controlled trial in which no such recommendations were given did not reveal any benefit of the alert system for the patients. In controlled but non-randomized trials, however, the provision of concrete treatment recommendations when the alert was activated led to more frequent implementation of diagnostic or therapeutic measures, less loss of renal function, lower in-hospital mortality, and lower mortality after discharge compared to control groups without an electronic alert for AKI. CONCLUSION: Non-randomized controlled trials of electronic alerts for AKI that were coupled with treatment recommendations have yielded evidence of improved care processes and treatment outcomes for patients with AKI. This review is limited by the low number of randomized trials and the wide variety of endpoints used in the studies that were evaluated.
BACKGROUND:Acute kidney injury (AKI) often takes a complicated course if diagnosed late and undertreated. Electronic alerts that provide an early warning of AKI are intended to support treating physicians in making the diagnosis of AKI and treating it appropriately. The available evidence on the effects of such alert systems is inconsistent. METHODS: We employed the PRISMA recommendations for systematic literature reviews to identify relevant articles in the PubMed, Scopus, and Web of Science databases. All of the studies that were retrieved were independently assessed by two of the authors with respect to the methods of computer-assisted electronic alert systems and their effects on process indicators and clinical endpoints. RESULTS: 16 studies with a total of 32 842 patients were identified. 8.5% of admitted patients had community-acquired or hospital-acquired AKI, with an in-hospital mortality of 22.8%. Fifteen electronic alert systems were in use throughout the participating hospitals. In 13 of 15 studies, alarm activation was accompanied by concrete treatment recommendations. A randomized controlled trial in which no such recommendations were given did not reveal any benefit of the alert system for the patients. In controlled but non-randomized trials, however, the provision of concrete treatment recommendations when the alert was activated led to more frequent implementation of diagnostic or therapeutic measures, less loss of renal function, lower in-hospital mortality, and lower mortality after discharge compared to control groups without an electronic alert for AKI. CONCLUSION: Non-randomized controlled trials of electronic alerts for AKI that were coupled with treatment recommendations have yielded evidence of improved care processes and treatment outcomes for patients with AKI. This review is limited by the low number of randomized trials and the wide variety of endpoints used in the studies that were evaluated.
Authors: Kirsten Colpaert; Eric A Hoste; Kristof Steurbaut; Dominique Benoit; Sofie Van Hoecke; Filip De Turck; Johan Decruyenaere Journal: Crit Care Med Date: 2012-04 Impact factor: 7.598
Authors: Allison B McCoy; Zachary L Cox; Erin B Neal; Lemuel R Waitman; Neeraja B Peterson; Gautam Bhave; Edward D Siew; Ioana Danciu; Julia B Lewis; Josh F Peterson Journal: Appl Clin Inform Date: 2012-06-13 Impact factor: 2.342
Authors: Allison B McCoy; Lemuel R Waitman; Cynthia S Gadd; Ioana Danciu; James P Smith; Julia B Lewis; Jonathan S Schildcrout; Josh F Peterson Journal: Am J Kidney Dis Date: 2010-08-14 Impact factor: 8.860
Authors: Nitin V Kolhe; Timothy Reilly; Janson Leung; Richard J Fluck; Kirsty E Swinscoe; Nicholas M Selby; Maarten W Taal Journal: Nephrol Dial Transplant Date: 2016-05-04 Impact factor: 5.992
Authors: Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin Journal: Crit Care Date: 2007 Impact factor: 9.097
Authors: Simon Sawhney; Angharad Marks; Nick Fluck; Adeera Levin; Gordon Prescott; Corri Black Journal: Am J Kidney Dis Date: 2016-08-21 Impact factor: 8.860
Authors: Anja Haase-Fielitz; Saban Elitok; Martin Schostak; Martin Ernst; Berend Isermann; Christian Albert; Bernt-Peter Robra; Andreas Kribben; Michael Haase Journal: Dtsch Arztebl Int Date: 2020-04-24 Impact factor: 5.594
Authors: Christian Albert; Michael Haase; Annemarie Albert; Antonia Zapf; Rüdiger Christian Braun-Dullaeus; Anja Haase-Fielitz Journal: Ann Lab Med Date: 2020-08-25 Impact factor: 3.464
Authors: Christian Albert; Michael Haase; Annemarie Albert; Siegfried Kropf; Rinaldo Bellomo; Sabine Westphal; Mark Westerman; Rüdiger Christian Braun-Dullaeus; Anja Haase-Fielitz Journal: Ann Lab Med Date: 2020-03 Impact factor: 3.464
Authors: Megan Howarth; Meha Bhatt; Eleanor Benterud; Anna Wolska; Evan Minty; Kyoo-Yoon Choi; Andrea Devrome; Tyrone G Harrison; Barry Baylis; Elijah Dixon; Indraneel Datta; Neesh Pannu; Matthew T James Journal: BMC Med Inform Decis Mak Date: 2020-11-04 Impact factor: 2.796